SG11201704781XA - Prevention of progressive heart failure - Google Patents

Prevention of progressive heart failure

Info

Publication number
SG11201704781XA
SG11201704781XA SG11201704781XA SG11201704781XA SG11201704781XA SG 11201704781X A SG11201704781X A SG 11201704781XA SG 11201704781X A SG11201704781X A SG 11201704781XA SG 11201704781X A SG11201704781X A SG 11201704781XA SG 11201704781X A SG11201704781X A SG 11201704781XA
Authority
SG
Singapore
Prior art keywords
prevention
heart failure
progressive heart
progressive
failure
Prior art date
Application number
SG11201704781XA
Other languages
English (en)
Inventor
Silviu Itescu
Lee Golden
Original Assignee
Mesoblast Int Sàrl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014905240A external-priority patent/AU2014905240A0/en
Application filed by Mesoblast Int Sàrl filed Critical Mesoblast Int Sàrl
Publication of SG11201704781XA publication Critical patent/SG11201704781XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
SG11201704781XA 2014-12-23 2015-12-22 Prevention of progressive heart failure SG11201704781XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2014905240A AU2014905240A0 (en) 2014-12-23 Prevention of progressive heart failure
PCT/EP2015/081048 WO2016102601A1 (fr) 2014-12-23 2015-12-22 Prévention de l'insuffisance cardiaque progressive

Publications (1)

Publication Number Publication Date
SG11201704781XA true SG11201704781XA (en) 2017-07-28

Family

ID=55080093

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704781XA SG11201704781XA (en) 2014-12-23 2015-12-22 Prevention of progressive heart failure

Country Status (9)

Country Link
US (2) US11491188B2 (fr)
EP (1) EP3237606A1 (fr)
JP (3) JP7315301B2 (fr)
KR (2) KR102660505B1 (fr)
CN (1) CN107206027A (fr)
AU (2) AU2015371011B2 (fr)
CA (1) CA2971514A1 (fr)
SG (1) SG11201704781XA (fr)
WO (1) WO2016102601A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1971679B1 (fr) 2006-01-13 2013-04-10 Osiris Therapeutics, Inc. Cellules souches mesenchymateuses exprimant le recepteur du tnf
WO2020157660A1 (fr) * 2019-01-28 2020-08-06 Mesoblast International Sárl Procédé de traitement ou de prévention de l'hémorragie digestive
US20220241334A1 (en) * 2019-07-03 2022-08-04 United States Government As Represented By The Department Of Veterans Affairs Compositions and methods for treating myocardium with mesenchymal stem cell scaffold
KR20230119676A (ko) * 2020-12-15 2023-08-16 메조블라스트 인터내셔널 에스에이알엘 클래스 ii 심부전 환자의 진행성 심부전 치료 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US7514074B2 (en) 1997-07-14 2009-04-07 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US7862810B2 (en) * 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20040258669A1 (en) 2002-11-05 2004-12-23 Dzau Victor J. Mesenchymal stem cells and methods of use thereof

Also Published As

Publication number Publication date
KR20240056789A (ko) 2024-04-30
CA2971514A1 (fr) 2016-06-30
AU2021240329A1 (en) 2021-10-28
WO2016102601A1 (fr) 2016-06-30
JP2024008950A (ja) 2024-01-19
US20170340674A1 (en) 2017-11-30
JP2022022396A (ja) 2022-02-03
JP7315301B2 (ja) 2023-07-26
EP3237606A1 (fr) 2017-11-01
AU2015371011A1 (en) 2017-06-29
US20230124294A1 (en) 2023-04-20
BR112017012912A2 (pt) 2018-01-02
JP7379452B2 (ja) 2023-11-14
US11491188B2 (en) 2022-11-08
JP2018500346A (ja) 2018-01-11
CN107206027A (zh) 2017-09-26
AU2015371011B2 (en) 2021-07-15
KR102660505B1 (ko) 2024-04-25
KR20170098862A (ko) 2017-08-30

Similar Documents

Publication Publication Date Title
IL250511A0 (en) Crystalline forms of ibrutinib
ZA201700880B (en) Polymorphs of selinexor
HK1258062A1 (zh) 給予惡拉戈利的方法
HK1213447A1 (zh) 雙不對稱鞋子
PL3640486T3 (pl) Mebel
IL285003A (en) Treatment of episode disorders
GB201410272D0 (en) Cardiac pump
IL252283A0 (en) Sublingual administration of riluzole
PL2940242T3 (pl) Złącze przepustowe blokujące ciśnienie
PL3204111T3 (pl) Układ do implantacji
SI3524234T1 (sl) Trdne oblike sofosbuvira
IL246979A0 (en) Crystalline forms of sofosbuvir
ZA201706282B (en) Solid forms of menaquinols
SG11201704781XA (en) Prevention of progressive heart failure
IL249130B (en) Preparation of piperidine-4-carbothioamide
GB2544217B (en) Chlorination of sucrose-6-esters
EP3317763C0 (fr) Mise en service d'entités virtualisées
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201403454D0 (en) Heart valve
AU2014905240A0 (en) Prevention of progressive heart failure
IL249332A0 (en) Crystalline forms of sofosbuvir
HK1215350A2 (zh) 防錯接線結構
GB201405142D0 (en) Theory of restoration
GB201511584D0 (en) Viprodi - Goblet of Fire
GB201414267D0 (en) Chlorination of sucrose-6-esters